Warning letter cites hormone creams
This article was originally published in The Tan Sheet
Executive Summary
Louisville, Ky.-based Cosmed Labs receives a warning letter from FDA saying online information and labeling position four products as hormone-containing drugs. The products - AIM Renewed Balance Body Cream, Products of Nature Natural Woman Progesterone Cream, Products of Nature Relevamine GS and Dr. Janet's Glucosamine Cream - are listed in the Aug. 3 letter. FDA also points out a number of the "objectionable" claims, including one for the glucosamine cream stating "the ingredients in this formula work to soothe joints." The agency says the products are unapproved drugs because all topically applied hormone products, except those containing hydrocortisone, are considered new drugs. Further, three of the formulas are misbranded because the adequacy of their indications has not been established, and all four are adulterated because production methods do not conform to drug good manufacturing practices
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.